Luthi & Co. is rated a Top-Tier IP firm, and the commentary is as follows:

"Luthi & Co does ‘an outstanding job of putting together the strongest possible legal position’. Its ‘client-oriented and eager’ team provides ‘very good, timely service’ across the IP spectrum but has particular strengths in life sciences and technology. It is representing GlaxoSmithKline in patent dispute with Unipharm regarding Avandia diabetes treatment, has been acting for MerckSerono in dispute over Rebif multiple sclerosis treatment, and acting for Hasbro in a copyright case.